Extracellular superoxide dismutase regulates cardiac function and fibrosis

Journal of Molecular and Cellular Cardiology

Volumn 47, Issue 5, 2009, Pages 730-742

  Kliment, Corrine R ^a   Suliman, Hagir B ^b   Tobolewski, Jacob M ^a   Reynolds, Crystal M ^b   Day, Brian J ^c   Zhu, Xiaodong ^a   McTiernan, Charles F ^a   McGaffin, Kenneth R ^a   Piantadosi, Claude A ^b   Oury, Tim D ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

^c DEPARTMENT OF MEDICINE   (United States)

Author keywords

Apoptosis; Cardiac fibrosis; Cardiomyopathy; Doxorubicin; Extracellular superoxide dismutase (EC SOD); Fibrosis; Oxygen free radicals

Indexed keywords

AEOL 10150; ANTIOXIDANT; DOXORUBICIN; HYDROXYPROLINE; METALLOPORPHYRIN; OXIDIZING AGENT; SUPEROXIDE DISMUTASE; UNCLASSIFIED DRUG;

ANIMAL TISSUE; APOPTOSIS; ARTICLE; C57BL 6 MOUSE; CARDIOTOXICITY; CELL INFILTRATION; CONTROLLED STUDY; ECHOCARDIOGRAPHY; ENZYME ACTIVITY; FEMALE; HEART DISEASE; HEART FUNCTION; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HEART LEFT VENTRICLE WALL; HEART MUSCLE FIBROSIS; HEART MUSCLE ISCHEMIA; HEART PROTECTION; HYPOTHESIS; INFLAMMATION; INFLAMMATORY CELL; KNOCKOUT MOUSE; LUNG FIBROSIS; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; WESTERN BLOTTING; WILD TYPE;

ANIMALS; BLOTTING, WESTERN; DOXORUBICIN; ECHOCARDIOGRAPHY; FEMALE; FIBROSIS; HEART; HYPERTROPHY, LEFT VENTRICULAR; IMMUNOHISTOCHEMISTRY; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MYOCARDIUM; OXIDATIVE STRESS; RANDOM ALLOCATION; SUPEROXIDE DISMUTASE;

MUS;

EID: 70349730231     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2009.08.010     Document Type: Article

References (49)

1. Chen E.P., Bittner H.B., Davis R.D., Folz R.J., and Van Trigt P. Extracellular superoxide dismutase transgene overexpression preserves postischemic myocardial function in isolated murine hearts. Circulation 94 9 Suppl (1996 Nov 1) II412-II417
2. Lu Z., Xu X., Hu X., Zhu G., Zhang P., van Deel E.D., et al. Extracellular superoxide dismutase deficiency exacerbates pressure overload-induced left ventricular hypertrophy and dysfunction. Hypertension 51 1 (2008 Jan) 19-25
3. Fattman C.L., Schaefer L.M., and Oury T.D. Extracellular superoxide dismutase in biology and medicine. Free Radic. Biol. Med. 35 3 (2003 Aug 1) 236-256
4. Folz R.J., and Crapo J.D. Extracellular superoxide dismutase (SOD3): tissue-specific expression, genomic characterization, and computer-assisted sequence analysis of the human EC SOD gene. Genomics 22 1 (1994 Jul 1) 162-171
5. Folz R.J., Guan J., Seldin M.F., Oury T.D., Enghild J.J., and Crapo J.D. Mouse extracellular superoxide dismutase: primary structure, tissue-specific gene expression, chromosomal localization, and lung in situ hybridization. Am. J. Respir. Cell Mol. Biol. 17 4 (1997 Oct) 393-403
6. Gao F., Koenitzer J.R., Tobolewski J.M., Jiang D., Liang J., Noble P.W., et al. Extracellular superoxide dismutase inhibits inflammation by preventing oxidative fragmentation of hyaluronan. J. Biol. Chem. 283 10 (2008 Mar 7) 6058-6066
7. Kliment C.R., Englert J.M., Gochuico B.R., Yu G., Kaminski N., Rosas I.O., et al. Oxidative stress alters syndecan-1 distribution in lungs with pulmonary fibrosis. J. Biol. Chem. (2008 Dec 9)
8. Kliment C.R., Tobolewski J.M., Manni M.L., Tan R.J., Enghild J., and Oury T.D. Extracellular superoxide dismutase protects against matrix degradation of heparan sulfate in the lung. Antioxidants Redox Signal. 10 2 (2008 Feb) 261-268
9. Petersen S.V., Oury T.D., Ostergaard L., Valnickova Z., Wegrzyn J., Thogersen I.B., et al. Extracellular superoxide dismutase (EC-SOD) binds to type I collagen and protects against oxidative fragmentation. J. Biol. Chem. 279 14 (2004 Apr 2) 13705-13710
10. Iida S., Chu Y., Weiss R.M., Kang Y.M., Faraci F.M., and Heistad D.D. Vascular effects of a common gene variant of extracellular superoxide dismutase in heart failure. Am. J. Physiol. Heart Circ. Physiol. 291 2 (2006 Aug) H914-H920
11. Petersen S.V., Olsen D.A., Kenney J.M., Oury T.D., Valnickova Z., Thogersen I.B., et al. The high concentration of Arg213->Gly extracellular superoxide dismutase (EC-SOD) in plasma is caused by a reduction of both heparin and collagen affinities. Biochem. J. 385 Pt 2 (2005 Jan 15) 427-432
12. Chu Y., Alwahdani A., Iida S., Lund D.D., Faraci F.M., and Heistad D.D. Vascular effects of the human extracellular superoxide dismutase R213G variant. Circulation 112 7 (2005 Aug 16) 1047-1053
13. Sharma S., Dewald O., Adrogue J., Salazar R.L., Razeghi P., Crapo J.D., et al. Induction of antioxidant gene expression in a mouse model of ischemic cardiomyopathy is dependent on reactive oxygen species. Free Radic. Biol. Med. 40 12 (2006 Jun 15) 2223-2231
14. van Deel E.D., Lu Z., Xu X., Zhu G., Hu X., Oury T.D., et al. Extracellular superoxide dismutase protects the heart against oxidative stress and hypertrophy after myocardial infarction. Free Radic. Biol. Med. 44 7 (2008 Apr 1) 1305-1313
15. Fattman C.L., Tan R.J., Tobolewski J.M., and Oury T.D. Increased sensitivity to asbestos-induced lung injury in mice lacking extracellular superoxide dismutase. Free Radic. Biol. Med. 40 4 (2006 Feb 15) 601-607
16. Tan R.J., Fattman C.L., Watkins S.C., and Oury T.D. Redistribution of pulmonary EC-SOD after exposure to asbestos. J. Appl. Physiol. 97 5 (2004 Nov) 2006-2013
17. Bowler R.P., Nicks M., Tran K., Tanner G., Chang L.Y., Young S.K., et al. Extracellular superoxide dismutase attenuates lipopolysaccharide-induced neutrophilic inflammation. Am. J. Respir. Cell Mol. Biol. 31 4 (2004 Oct) 432-439
18. Singal P.K., and Iliskovic N. Doxorubicin-induced cardiomyopathy. N. Engl. J. Med. 339 13 (1998 Sep 24) 900-905
19. Konorev E.A., Kotamraju S., Zhao H., Kalivendi S., Joseph J., and Kalyanaraman B. Paradoxical effects of metalloporphyrins on doxorubicin-induced apoptosis: scavenging of reactive oxygen species versus induction of heme oxygenase-1. Free Radic. Biol. Med. 33 7 (2002 Oct 1) 988
20. Kachadourian R., Johnson C.A., Min E., Spasojevic I., and Day B.J. Flavin-dependent antioxidant properties of a new series of meso-N,N′-dialkyl-imidazolium substituted manganese(III) porphyrins. Biochem. Pharmacol. 67 1 (2004 Jan 1) 77-85
21. Carlsson L.M., Jonsson J., Edlund T., and Marklund S.L. Mice lacking extracellular superoxide dismutase are more sensitive to hyperoxia. Proc. Natl. Acad. Sci. U. S. A. 92 14 (1995 Jul 3) 6264-6268
22. Kadokami T., McTiernan C.F., Kubota T., Frye C.S., and Feldman A.M. Sex-related survival differences in murine cardiomyopathy are associated with differences in TNF-receptor expression. J. Clin. Invest. 106 4 (2000 Aug) 589-597
23. McGaffin K.R., Sun C.K., Rager J.J., Romano L.C., Zou B., Mathier M.A., et al. Leptin signalling reduces the severity of cardiac dysfunction and remodelling after chronic ischaemic injury. Cardiovasc. Res. 77 1 (2008 Jan) 54-63
24. Janczewski A.M., Zahid M., Lemster B.H., Frye C.S., Gibson G., Higuchi Y., et al. Phospholamban gene ablation improves calcium transients but not cardiac function in a heart failure model. Cardiovasc. Res. 62 3 (2004 Jun 1) 468-480
25. Englert J.M., Hanford L.E., Kaminski N., Tobolewski J.M., Tan R.J., Fattman C.L., et al. A role for the receptor for advanced glycation end products in idiopathic pulmonary fibrosis. Am. J. Pathol. 172 3 (2008 Mar) 583-591
26. Woessner Jr. J.F. The determination of hydroxyproline in tissue and protein samples containing small proportions of this imino acid. Arch. Biochem. Biophys. 93 (1961 May) 440-447
27. Oury T.D., Chang L.Y., Marklund S.L., Day B.J., and Crapo J.D. Immunocytochemical localization of extracellular superoxide dismutase in human lung. Lab. Invest.; J. Tech. Methods Pathol. 70 6 (1994 Jun) 889-898
28. Junqueira L.C., Bignolas G., and Brentani R.R. Picrosirius staining plus polarization microscopy, a specific method for collagen detection in tissue sections. Histochem. J. 11 4 (1979 Jul) 447-455
29. Whittaker P., Kloner R.A., Boughner D.R., and Pickering J.G. Quantitative assessment of myocardial collagen with picrosirius red staining and circularly polarized light. Basic Res. Cardiol. 89 5 (1994 Sep-Oct) 397-410
30. Piantadosi C.A., Carraway M.S., Babiker A., and Suliman H.B. Heme oxygenase-1 regulates cardiac mitochondrial biogenesis via Nrf2-mediated transcriptional control of nuclear respiratory factor-1. Circ. Res. 103 11 (2008 Nov 21) 1232-1240
31. Nozik-Grayck E., Suliman H.B., and Piantadosi C.A. Extracellular superoxide dismutase. Int. J. Biochem. Cell Biol. 37 12 (2005 Dec) 2466-2471
32. Konorev E.A., Kennedy M.C., and Kalyanaraman B. Cell-permeable superoxide dismutase and glutathione peroxidase mimetics afford superior protection against doxorubicin-induced cardiotoxicity: the role of reactive oxygen and nitrogen intermediates. Arch. Biochem. Biophys. 368 2 (1999 Aug 15) 421-428
33. Fattman C.L., Chang L.Y., Termin T.A., Petersen L., Enghild J.J., and Oury T.D. Enhanced bleomycin-induced pulmonary damage in mice lacking extracellular superoxide dismutase. Free Radic. Biol. Med. 35 7 (2003 Oct 1) 763-771
34. Folz R.J., Abushamaa A.M., and Suliman H.B. Extracellular superoxide dismutase in the airways of transgenic mice reduces inflammation and attenuates lung toxicity following hyperoxia. J. Clin. Invest. 103 7 (1999 Apr) 1055-1066
35. Rabbani Z.N., Batinic-Haberle I., Anscher M.S., Huang J., Day B.J., Alexander E., et al. Long-term administration of a small molecular weight catalytic metalloporphyrin antioxidant, AEOL 10150, protects lungs from radiation-induced injury. Int. J. Radiat. Oncol. Biol. Phys. 67 2 (2007 Feb 1) 573-580
36. Kalyanaraman B., Joseph J., Kalivendi S., Wang S., Konorev E., and Kotamraju S. Doxorubicin-induced apoptosis: implications in cardiotoxicity. Mol. Cell. Biochem. 234-235 1-2 (2002 May-Jun) 119-124
37. Kalyanaraman B., Perez-Reyes E., and Mason R.P. Spin-trapping and direct electron spin resonance investigations of the redox metabolism of quinone anticancer drugs. Biochim. Biophys. Acta 630 1 (1980 Jun 5) 119-130
38. Vasquez-Vivar J., Martasek P., Hogg N., Masters B.S., Pritchard Jr. K.A., and Kalyanaraman B. Endothelial nitric oxide synthase-dependent superoxide generation from adriamycin. Biochemistry 36 38 (1997 Sep 23) 11293-11297
39. Harris R.N., and Doroshow J.H. Effect of doxorubicin-enhanced hydrogen peroxide and hydroxyl radical formation on calcium sequestration by cardiac sarcoplasmic reticulum. Biochem. Biophys. Res. Commun. 130 2 (1985 Jul 31) 739-745
40. Nozik-Grayck E., Huang Y.C., Carraway M.S., and Piantadosi C.A. Bicarbonate-dependent superoxide release and pulmonary artery tone. Am. J. Physiol. Heart Circ. Physiol. 285 6 (2003 Dec) H2327-H2335
41. Takimoto E., Champion H.C., Li M., Ren S., Rodriguez E.R., Tavazzi B., et al. Oxidant stress from nitric oxide synthase-3 uncoupling stimulates cardiac pathologic remodeling from chronic pressure load. J. Clin. Invest. 115 5 (2005 May) 1221-1231
42. Kalivendi S.V., Kotamraju S., Zhao H., Joseph J., and Kalyanaraman B. Doxorubicin-induced apoptosis is associated with increased transcription of endothelial nitric-oxide synthase. Effect of antiapoptotic antioxidants and calcium. J. Biol. Chem. 276 50 (2001 Dec 14) 47266-47276
43. Neilan T.G., Blake S.L., Ichinose F., Raher M.J., Buys E.S., Jassal D.S., et al. Disruption of nitric oxide synthase 3 protects against the cardiac injury, dysfunction, and mortality induced by doxorubicin. Circulation 116 5 (2007 Jul 31) 506-514
44. Berka V., Wu G., Yeh H.C., Palmer G., and Tsai A.L. Three different oxygen-induced radical species in endothelial nitric-oxide synthase oxygenase domain under regulation by l-arginine and tetrahydrobiopterin. J. Biol. Chem. 279 31 (2004 Jul 30) 32243-32251
45. Adachi T., Yamada H., Yamada Y., Morihara N., Yamazaki N., Murakami T., et al. Substitution of glycine for arginine-213 in extracellular-superoxide dismutase impairs affinity for heparin and endothelial cell surface. Biochem. J. 313 Pt 1 (1996 Jan 1) 235-239
46. Folz R.J., Peno-Green L., and Crapo J.D. Identification of a homozygous missense mutation (Arg to Gly) in the critical binding region of the human EC-SOD gene (SOD3) and its association with dramatically increased serum enzyme levels. Hum. Mol. Genet. 3 12 (1994 Dec) 2251-2254
47. Adachi T., Ohta H., Yamada H., Futenma A., Kato K., and Hirano K. Quantitative analysis of extracellular-superoxide dismutase in serum and urine by ELISA with monoclonal antibody. Clin. Chim. Acta 212 3 (1992 Nov 30) 89-102
48. Adachi T., Yamazaki N., Tasaki H., Toyokawa T., Yamashita K., and Hirano K. Changes in the heparin affinity of extracellular-superoxide dismutase in patients with coronary artery atherosclerosis. Biol. Pharm. Bull. 21 10 (1998 Oct) 1090-1093
49. Juul K., Tybjaerg-Hansen A., Marklund S., Heegaard N.H., Steffensen R., Sillesen H., et al. Genetically reduced antioxidative protection and increased ischemic heart disease risk: The Copenhagen City Heart Study. Circulation 109 1 (2004 Jan 6) 59-65